Snowball logo
logo
1734_logo

Sinphar Pharmaceutical Co Ltd

1734 โ€ข TW
NT$31.85NT$0.00ย  (0%)
Estimate
P/E
19.7
EPS
1.62
Beta
0.072
Growth
Revenue, YoY
2.61%
Net income, YoY
-34.33%
FCF, YoY
-54.03%
Forecast
P/E (FWD)
14.6
EPS (FWD)
2.18
About the company
Ticker
1734
ISIN
TW0001734002
Country
Taiwan
Sector (GICS)
Healthcare
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

Frequently asked questions

What sector does Sinphar Pharmaceutical Co Ltd (1734) operate in?

Sinphar Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Sinphar Pharmaceutical Co Ltd (1734) current stock price?

As of the latest data, Sinphar Pharmaceutical Co Ltd stock price is NT$31.85, with a previous close of NT$31.85.

What is Sinphar Pharmaceutical Co Ltd (1734) current market capitalization?

Sinphar Pharmaceutical Co Ltd market cap is approximately 6.42 billion.

What is Sinphar Pharmaceutical Co Ltd (1734) Earnings Per Share (EPS)?

The trailing EPS is NT$1.62, and the forward EPS is NT$2.18.

What is Sinphar Pharmaceutical Co Ltd (1734) Price-to-Earnings (P/E) ratio?

Sinphar Pharmaceutical Co Ltd current P/E ratio is 19.66, with a forward P/E of 14.61.

What is Sinphar Pharmaceutical Co Ltd (1734) EBITDA?

Sinphar Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 155.71 million.

Does Sinphar Pharmaceutical Co Ltd (1734) pay dividends?

No. Sinphar Pharmaceutical Co Ltd does not pay a dividend.

What is Sinphar Pharmaceutical Co Ltd (1734) beta (volatility) score?

Sinphar Pharmaceutical Co Ltd has a beta of 0.072, indicating lower volatility than the overall market.